Literature DB >> 27530333

Relation of Plasma Lipoprotein(a) to Subclinical Coronary Plaque Volumes, Three-Vessel and Left Main Coronary Disease, and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease.

Brian G Kral1, Rita R Kalyani2, Lisa R Yanek2, Dhananjay Vaidya2, Elliot K Fishman3, Diane M Becker2, Lewis C Becker4.   

Abstract

Serum lipoprotein(a) [Lp(a)] is a coronary artery disease (CAD) risk factor in persons of European ancestry. Levels are twofold to threefold higher in African-Americans (AAs), but reported associations with CAD have been inconsistent. The relation of Lp(a) with the extent and severity of subclinical coronary plaque has not been described in AAs. We screened 269 apparently healthy AAs for risk factors and coronary plaque using advanced coronary computed tomographic angiography. Total coronary plaque (TCP), noncalcified coronary plaque, and calcified coronary plaque volumes (mm(3)) were quantified using a validated automated method. Lp(a) was measured by ELISA. Multivariable modeling was performed with adjustment for traditional CAD risk factors and intrafamilial correlations. Mean age was 51 ± 11 years and 64% were female. Plaque was present in 41%. Lp(a) was independently associated with TCP volume [log(TCP + 1)] (p = 0.04), 3-vessel and/or left main involvement (p = 0.04), and at least 1 stenosis >50% (p = 0.006). Best-fit regression analyses showed that subjects with Lp(a) >40 mg/dl were threefold more likely to have 3-vessel and/or left main disease (95% confidence interval 1.4 to 6.8, p = 0.005) and fourfold more likely to have stenosis >50% (95% confidence interval 1.3 to 15.0, p = 0.02). In subjects with plaque (n = 110), multivariable models showed the Lp(a) level was significantly and independently associated with TCP (p = 0.009), noncalcified coronary plaque (p = 0.01), and calcified coronary plaque (p = 0.003) and affected vessel length (p = 0.01). In conclusion, high Lp(a) is strongly associated with coronary plaque volumes, extent, and severity in apparently healthy AAs. High levels of Lp(a) may be particularly important in the pathogenesis of CAD in AAs.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27530333      PMCID: PMC4991623          DOI: 10.1016/j.amjcard.2016.06.020

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography.

Authors:  Udo Hoffmann; Fabian Moselewski; Koen Nieman; Ik-Kyung Jang; Maros Ferencik; Ayaz M Rahman; Ricardo C Cury; Suhny Abbara; Hamid Joneidi-Jafari; Stephan Achenbach; Thomas J Brady
Journal:  J Am Coll Cardiol       Date:  2006-03-27       Impact factor: 24.094

Review 2.  Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.

Authors:  Arjun Deb; Noel M Caplice
Journal:  Clin Cardiol       Date:  2004-05       Impact factor: 2.882

3.  Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.

Authors:  David-Alexandre Trégouët; Inke R König; Jeanette Erdmann; Alexandru Munteanu; Peter S Braund; Alistair S Hall; Anika Grosshennig; Patrick Linsel-Nitschke; Claire Perret; Maylis DeSuremain; Thomas Meitinger; Ben J Wright; Michael Preuss; Anthony J Balmforth; Stephen G Ball; Christa Meisinger; Cécile Germain; Alun Evans; Dominique Arveiler; Gérald Luc; Jean-Bernard Ruidavets; Caroline Morrison; Pim van der Harst; Stefan Schreiber; Katharina Neureuther; Arne Schäfer; Peter Bugert; Nour E El Mokhtari; Jürgen Schrezenmeir; Klaus Stark; Diana Rubin; H-Erich Wichmann; Christian Hengstenberg; Willem Ouwehand; Andreas Ziegler; Laurence Tiret; John R Thompson; Francois Cambien; Heribert Schunkert; Nilesh J Samani
Journal:  Nat Genet       Date:  2009-02-08       Impact factor: 38.330

4.  Automated 3-dimensional quantification of noncalcified and calcified coronary plaque from coronary CT angiography.

Authors:  Damini Dey; Victor Y Cheng; Piotr J Slomka; Ryo Nakazato; Amit Ramesh; Swaminatha Gurudevan; Guido Germano; Daniel S Berman
Journal:  J Cardiovasc Comput Tomogr       Date:  2009-10-01

5.  Lipoprotein(a) is an important factor to determine coronary artery plaque morphology in patients with acute myocardial infarction.

Authors:  Hiroyuki Hikita; Takatoshi Shigeta; Keisuke Kojima; Yuki Oosaka; Keiichi Hishikari; Naohiko Kawaguchi; Emiko Nakashima; Tomoyo Sugiyama; Daiki Akiyama; Tetsuo Kamiishi; Shigeki Kimura; Yoshihide Takahashi; Taishi Kuwahara; Akira Sato; Atsushi Takahashi; Mitsuaki Isobe
Journal:  Coron Artery Dis       Date:  2013-08       Impact factor: 1.439

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  Automated three-dimensional quantification of noncalcified coronary plaque from coronary CT angiography: comparison with intravascular US.

Authors:  Damini Dey; Tiziano Schepis; Mohamed Marwan; Piotr J Slomka; Daniel S Berman; Stephan Achenbach
Journal:  Radiology       Date:  2010-09-09       Impact factor: 11.105

8.  Differences in plaque composition and distribution in stable coronary artery disease versus acute coronary syndromes; non-invasive evaluation with multi-slice computed tomography.

Authors:  J D Schuijf; T Beck; C Burgstahler; J Wouter Jukema; M S Dirksen; A de Roos; E E van der Wall; S Schroeder; W Wijns; J J Bax
Journal:  Acute Card Care       Date:  2007

9.  Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)

Authors:  W Terres; E Tatsis; B Pfalzer; F U Beil; U Beisiegel; C W Hamm
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

10.  Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis.

Authors:  T Budde; C Fechtrup; E Bösenberg; C Vielhauer; A Enbergs; H Schulte; G Assmann; G Breithardt
Journal:  Arterioscler Thromb       Date:  1994-11
View more
  8 in total

1.  Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis.

Authors:  Brian T Steffen; George Thanassoulis; Daniel Duprez; James H Stein; Amy B Karger; Mathew C Tattersall; Joel D Kaufman; Weihua Guan; Michael Y Tsai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

2.  Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a).

Authors:  Michael J Koren; Monica Florio; Patrick Maurice Moriarty; Seth J Baum; Joel Neutel; Martha Hernandez-Illas; Howard S Weintraub; Helina Kassahun; Stacey Melquist; Tracy Varrieur; Saptarsi M Haldar; Winnie Sohn; Huei Wang; Mary Elliott-Davey; Brooke M Rock; Tao Pei; Oliver Homann; Jennifer Hellawell; Gerald F Watts
Journal:  Nat Med       Date:  2022-01-13       Impact factor: 87.241

3.  Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study.

Authors:  Yusuke Muramatsu; Yoshiyasu Minami; Ayami Kato; Aritomo Katsura; Toshimitsu Sato; Ryota Kakizaki; Teruyoshi Nemoto; Takuya Hashimoto; Kazuhiro Fujiyoshi; Kentaro Meguro; Takao Shimohama; Junya Ako
Journal:  Int J Cardiol Heart Vasc       Date:  2019-06-13

Review 4.  Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction.

Authors:  Enas A Enas; Basil Varkey; T S Dharmarajan; Guillaume Pare; Vinay K Bahl
Journal:  Indian Heart J       Date:  2019-03-20

5.  Serum Lipoprotein (a) levels in acute coronary syndrome; Comparison of younger and elderly patients with healthy controls.

Authors:  Sadaf Hanif; Bilqees Akhtar; Muhammad Naeem Afzal
Journal:  Pak J Med Sci       Date:  2019 Nov-Dec       Impact factor: 1.088

6.  Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular Ultrasound.

Authors:  Chetan P Huded; Nishant P Shah; Rishi Puri; Stephen J Nicholls; Kathy Wolski; Steven E Nissen; Leslie Cho
Journal:  J Am Heart Assoc       Date:  2020-11-23       Impact factor: 5.501

Review 7.  Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.

Authors:  Enas A Enas; Basil Varkey; T S Dharmarajan; Guillaume Pare; Vinay K Bahl
Journal:  Indian Heart J       Date:  2019-05-02

8.  Discordance of Low-Density Lipoprotein Cholestrol and Non-High-Density Lipoprotein Cholestrol and Coronary Artery Disease Severity.

Authors:  Ozge Kurmus; Aycan Fahri Erkan; Berkay Ekici; Turgay Aslan; Murat Eren
Journal:  Arq Bras Cardiol       Date:  2020-03       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.